A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (3) , 347-350
- https://doi.org/10.1016/0959-8049(93)90383-q
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Journal of Clinical Oncology, 1990
- A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract.Journal of Clinical Oncology, 1989
- New Combination Chemotherapy Programme for Bladder CancerBritish Journal of Urology, 1989
- M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1988
- Chemotherapy of urothelial tract tumorsCancer, 1987
- Combination Chemotherapy with Cisplatin and Methotrexate in Advanced Transitional Cell Cancer of the BladderJournal of Urology, 1987
- Methotrexate, Cisplatin and Carboplatin as Single Agents and in Combination for Metastatic Bladder CancerBritish Journal of Urology, 1986
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985
- Cis‐platin and Methotrexate in the Treatment of Transitional Cell Carcinoma of the Urinary TractBritish Journal of Urology, 1985
- Reporting results of cancer treatmentCancer, 1981